Bsx Stock Buy Or Sell Now

: Despite trimming price targets, the consensus remains a Moderate Buy .

: The company reported Q1 2026 revenue of $5.20B and adjusted EPS of $0.80, both slightly beating market expectations. bsx stock buy or sell

As of late April 2026, Boston Scientific (BSX) presents a complex "show-me" story for investors. While Wall Street remains broadly bullish, recent guidance cuts and competitive pressures have shifted the narrative from hyper-growth to a more cautious defensive stance. The Buy Case: A Value Opportunity? : Despite trimming price targets, the consensus remains

We use a cookie-less web analysis tool (etracker). For more information and to opt-out, please click here.